Fibromyalgia Syndrome on Anthropometric and Ultrasonographic Measurements in Obstructive Sleep Apnea Syndrome

Kirsehir Ahi Evran Universitesi77 enrolled

Overview

Obstructive type sleep apnea syndrome is a clinical condition characterized by apnea, hypopnea and oxygen desaturation due to narrowing of the upper airway during sleep. Obesity is considered a major predisposing factor for OSAS. In addition, various recent studies have reported that various anthropometric measurements such as neck circumference, waist circumference, hip circumference, waist-hip ratio, neck-waist circumference ratio change (increase) in OSAS patients.

Fibromyalgia is a common health problem that is characterized by pain in various parts of the body and is very difficult to diagnose and treat. It affects 2-4% of the population and is more common in women. The presence of OSAS in fibromyalgia patients is more common than in the normal population. There are also common additional symptoms such as excessive daytime sleepiness and delayed sleep latency. Although it has been reported that the presence of OSAS is more common in fibromyalgia patients, there is no study on the presence of anthropometric measurements, especially neck circumference, that are accepted in OSAS. The aim of this study is to compare the anthropometric and ultrasonographic measurements of female OSAS patients with and without fibromyalgia.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Fibromyalgia Syndrome Obstructive Sleep Apnea Syndrome

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Between 18-65 years old * Being diagnosed with fibromyalgia and having applied to the sleep disorders outpatient clinic or being followed up with the diagnosis of OSAS in the sleep disorders outpatient clinic. * Agree to participate in the study Exclusion Criteria: * Patients under 18 years of age * Male patients * Not agreeing to participate in the study * Neurological diseases that may cause OSAS such as stroke, Parkinson's disease, multiple sclerosis * Rheumatological, oncological and hematological diseases * Central type obstructive sleep apnea syndrome * Thyroid pathology that affects neck circumference measurement

Outcomes

Primary Outcomes

Anthropometric Measurements

Anthropometric measurements will be taken for all patients. These measurements include neck circumference, waist circumference, hip circumference, and with these data, waist-hip ratio and neck-waist circumference ratio will be calculated. Measurements will be made with a tape measure and with patient consent.

Time frame: Day 0 ( Baseline)

Polisomnografi- SLEEP LATENCE

Sleep latency time will be measured in polysomnography

Time frame: Day 0 ( Baseline)

Polisomnografi -SLEEP ACTIVITY

Sleep efficiency will be measured during polysomnography

Time frame: Day 0 ( Baseline)

Polisomnografi -REM time

REM time will be measured in minutes during polysomnography

Time frame: Day 0 ( Baseline)

Polisomnografi -NREM STAGES

During polysomnography, NREM stages will be measured at 1 min, 2 min, and 3 min.

Time frame: Day 0 ( Baseline)

Polisomnografi - NUMBERS OF APNE

Numbers of apnea will be recorded in polysomnographic measurements.

Time frame: Day 0 ( Baseline)

Polisomnografi -NUMBER OF HYPOPNEA

Numbers of hypopnea will be recorded in polysomnographic measurements

Time frame: Day 0 ( Baseline)

Polisomnografi -Apnea hypopnea index (AHI) in polysomnography; Apnea hypopnea index (AHI) will be evaluated on a supine, non-supine basis.

Apnea hypopnea index (AHI) will be evaluated in polysomnography.According to the AHI level; It will be classified as SIMPLE SNORING (AHİ\<5), LIGHT OSAS (AHİ 5-15), MEDIUM OSAS (AHİ 15-30), HEAVY OSAS (AHİ 30+ )

Time frame: Day 0 ( Baseline)

Polisomnografi-REM

REM times will be evaluated in polysomnography

Time frame: Day 0 ( Baseline)

Polisomnografi-NonREM

NonREM times will be evaluated in polysomnography

Time frame: Day 0 ( Baseline)

Polisomnografi -Apnea hypopnea index (AHI) REM, NONREM in polysomnography; Apnea hypopnea index (AHI) will be evaluated on a supine, non-supine basis.

Apnea hypopnea index (AHI) will be evaluated as REM, NONREM, Supine, non-supine in polysomnography.According to the AHI level; It will be classified as SIMPLE SNORING (AHİ\<5), LIGHT OSAS (AHİ 5-15), MEDIUM OSAS (AHİ 15-30), HEAVY OSAS (AHİ 30+ )

Time frame: Day 0 ( Baseline)

Polisomnografi -OXYGEN DESATURATION INDEX

Minimum oxygen saturation and average oxygen saturation will be measured in polysomnography.

Time frame: Day 0 ( Baseline)

submental ultrasonography

All patients will undergo submental ultrasonography to measure tongue base thickness and lateral pharyngeal wall thickness.

Time frame: Day 0 ( Baseline)

Secondary Outcomes

Pittsburgh Sleep Quality Index

The Pittsburgh Sleep Quality Index will be used to evaluate sleep quality. The survey consists of 21 questions and a high score indicates poor sleep quality.

Time frame: Day 0 ( Baseline)

Fibromyalgia Impact Scale

The fibromyalgia levels of the participants will be evaluated with the Fibromyalgia Impact Scale. High scores indicate increased disease activity. Consists of 10 questions Maximum score is 80. Turkish validity and reliability was done

Time frame: Day 0 ( Baseline)

Fibromyalgia Syndrome on Anthropometric and Ultrasonographic Measurements in Obstructive Sleep Apnea Syndrome

Overview

Conditions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Secondary Outcomes